다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
BioPlus Acquisition Corporation (BIOSU)
BioPlus Acquisition Corporation (BIOSU) 뉴스

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIOSU

1

일자	시간	출처	헤드라인	심볼	기업
2023/10/17	05:15	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/10/04	20:39	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/10/04	20:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/10/04	20:30	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/09/16	05:00	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/08/16	22:01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/08/15	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/07/17	21:01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/06/14	19:09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/06/14	19:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/31	05:04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/20	05:50	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/20	05:05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/16	05:29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/15	19:38	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/13	05:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/03	21:47	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/05/03	21:44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/04/28	05:35	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/02/15	05:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2023/02/03	00:10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/11/04	06:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/10/12	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/08/11	05:33	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/05/13	05:55	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/03/12	06:05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2022/02/10	04:14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2021/12/06	22:00	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOSU	BioPlus Acquisition Corporation
2021/12/03	10:55	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOSU	BioPlus Acquisition Corporation

검색 관련기사 보기:NASDAQ:BIOSU

1

US Dollar vs Yen

BNP Paribas (QX)

US Dollar vs Sterling

Verizon Communications

Bank of America

Health Care Select Sector

American Express

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관